首页 > 最新文献

Experimental gerontology最新文献

英文 中文
Is playing ma-jong, chess and cards associated with a lower incidence of shoulder pain in Chinese elderly adults? The cross-sectional and longitudinal evidence from CHARLS 打麻将、下棋和打牌是否与中国老年人较低的肩痛发病率有关?来自 CHARLS 的横断面和纵向证据。
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112518
Yinong He , Chenrui Yuan , Yifei Wang , Hui Xu , Wei Song , Wencai Liu

Background

The association between playing Ma-jong, chess and cards (PMCC) and shoulder pain among elderly adults in China remains unclear. The present study aimed to examine the association based on a nationally representative large-scale survey.

Methods

The study used two waves of data from China Health and Retirement Longitudinal Study (CHARLS) in 2015 and 2018. All subjects met the inclusion criteria were classified based on the results of the CHARLS wave questionnaire. Logistic regression models were conducted to analyze the cross-sectional and longitudinal association between PMCC and shoulder pain. Odds ratios (OR) were reported to indicate the strength of the association.

Results

In total, 8125 participants aged over 60 years (48.3 % male; mean age 67.9 ± 6.4 years) were enrolled in a cross-sectional association study in 2015, and further 6861 elderly adults were followed up in 2018. The overall prevalence of shoulder pain in the cross-sectional population was 15.6 %. In the non-PMCC and PMCC groups, the incidence of shoulder pain was 16.6 % and 10.7 %, respectively (P < 0.001). In the fully adjusted model, the results showed a significant association between PMCC and shoulder pain (OR: 0.798, 95 % CI: 0.662–0.963, P = 0.018). In the longitudinal analysis from 2015 to 2018, the incidence of new-occurrence shoulder pain in non-PMCC and PMCC groups was 22.1 %, and 18.5 %, respectively (P = 0.004). In the fully adjusted model, compared with the non-PMCC group, the risk of the occurrence of shoulder pain for individuals with PMCC was lower (OR: 0.832, 95 % CI: 0.709–0.975, P = 0.023).

Conclusions

PMCC is associated with lower incidence of shoulder pain, which provides evidence for PMCC as a potential protective factor in the occurrence of shoulder pain.

背景:中国老年人打麻将、下棋和打牌(PMCC)与肩痛之间的关系尚不清楚。本研究旨在通过一项具有全国代表性的大规模调查来研究两者之间的关系:研究使用了中国健康与退休纵向研究(CHARLS)2015年和2018年的两波数据。所有符合纳入标准的受试者均根据CHARLS波次问卷调查结果进行分类。研究采用逻辑回归模型分析了PMCC与肩痛之间的横向和纵向关联。结果显示,有8125名年龄在40岁以上的参与者患有PMCC:2015年共有8125名60岁以上的参与者(48.3%为男性;平均年龄(67.9±6.4)岁)参加了横断面关联研究,2018年又对6861名老年人进行了随访。在横断面人群中,肩痛的总体患病率为 15.6%。在非PMCC组和PMCC组中,肩痛发生率分别为16.6%和10.7%(P 结论:PMCC与肩痛发生率较低有关:PMCC与较低的肩痛发生率相关,这为PMCC作为肩痛发生的潜在保护因素提供了证据。
{"title":"Is playing ma-jong, chess and cards associated with a lower incidence of shoulder pain in Chinese elderly adults? The cross-sectional and longitudinal evidence from CHARLS","authors":"Yinong He ,&nbsp;Chenrui Yuan ,&nbsp;Yifei Wang ,&nbsp;Hui Xu ,&nbsp;Wei Song ,&nbsp;Wencai Liu","doi":"10.1016/j.exger.2024.112518","DOIUrl":"10.1016/j.exger.2024.112518","url":null,"abstract":"<div><h3>Background</h3><p>The association between playing Ma-jong, chess and cards (PMCC) and shoulder pain among elderly adults in China remains unclear. The present study aimed to examine the association based on a nationally representative large-scale survey.</p></div><div><h3>Methods</h3><p>The study used two waves of data from China Health and Retirement Longitudinal Study (CHARLS) in 2015 and 2018. All subjects met the inclusion criteria were classified based on the results of the CHARLS wave questionnaire. Logistic regression models were conducted to analyze the cross-sectional and longitudinal association between PMCC and shoulder pain. Odds ratios (OR) were reported to indicate the strength of the association.</p></div><div><h3>Results</h3><p>In total, 8125 participants aged over 60 years (48.3 % male; mean age 67.9 ± 6.4 years) were enrolled in a cross-sectional association study in 2015, and further 6861 elderly adults were followed up in 2018. The overall prevalence of shoulder pain in the cross-sectional population was 15.6 %. In the non-PMCC and PMCC groups, the incidence of shoulder pain was 16.6 % and 10.7 %, respectively (<em>P</em> &lt; 0.001). In the fully adjusted model, the results showed a significant association between PMCC and shoulder pain (OR: 0.798, 95 % CI: 0.662–0.963, <em>P</em> = 0.018). In the longitudinal analysis from 2015 to 2018, the incidence of new-occurrence shoulder pain in non-PMCC and PMCC groups was 22.1 %, and 18.5 %, respectively (<em>P</em> = 0.004). In the fully adjusted model, compared with the non-PMCC group, the risk of the occurrence of shoulder pain for individuals with PMCC was lower (OR: 0.832, 95 % CI: 0.709–0.975, <em>P</em> = 0.023).</p></div><div><h3>Conclusions</h3><p>PMCC is associated with lower incidence of shoulder pain, which provides evidence for PMCC as a potential protective factor in the occurrence of shoulder pain.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001608/pdfft?md5=d9f35cd0a5fc5d6d42f376c12235ae8d&pid=1-s2.0-S0531556524001608-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the therapeutic effects of a Japanese sake yeast supplement on a zebrafish model of Parkinson's disease: Antioxidant and inflammatory responses 研究日本清酒酵母补充剂对帕金森病斑马鱼模型的治疗效果:抗氧化和炎症反应
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112509
Chang Li , Meihe Li , Yi Jin , Qing An , Huimin Dang , Wei Gong

Sake may potentially halt the progression of Parkinson's disease due to its properties, yet no studies have explored its effects. This preliminary study aimed to assess the impact of sake supplementation on Parkinson's disease using a zebrafish model. Sixty fish were divided into six groups: control, rotenone (ROT), and groups administered rotenone along with sake at concentrations of 25, 50, 75, and 100 mg/L (25S, 50S, 75S, and 100S). After 28 days of treatment, behavioral responses and the activities of catalase (CAT), superoxide dismutase (SOD), reduced glutathione (GSH), and glutathione-S-transferase (GST), as well as the expressions of TNF-α, IL-1β, and COX-2, were evaluated. The results indicated that rotenone administration significantly reduced crossing number (P = 0.001), entries in the top area (P = 0.001), and time spent in the top area (P = 0.001). It also markedly increased levels of TBARS and SH compared to the control group (P = 0.001). Rotenone significantly decreased CAT, SOD, and GSH activities while increasing GST levels. Furthermore, it upregulated the expressions of TNF-α (P = 0.001), IL-1β (P = 0.001), and COX-2 (P = 0.001). Supplementation with sake, particularly at higher doses, reversed the adverse effects of rotenone on behavioral, oxidative, and inflammatory responses. In conclusion, sake shows promise for preventing Parkinson's disease pending further clinical studies.

清酒的特性可能会阻止帕金森病的发展,但目前还没有研究探讨清酒的影响。这项初步研究旨在利用斑马鱼模型评估清酒补充剂对帕金森病的影响。60 条斑马鱼被分为六组:对照组、鱼藤酮组(ROT)、在服用鱼藤酮的同时服用清酒的组,浓度分别为 25、50、75 和 100 毫克/升(25S、50S、75S 和 100S)。治疗 28 天后,评估了行为反应、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)和谷胱甘肽转移酶(GST)的活性以及 TNF-α、IL-1β 和 COX-2 的表达。结果表明,鱼藤酮能显著减少交叉数量(P = 0.001)、顶部区域的进入次数(P = 0.001)和顶部区域的停留时间(P = 0.001)。与对照组相比,它还显著增加了 TBARS 和 SH 的水平(P = 0.001)。轮酮明显降低了 CAT、SOD 和 GSH 活性,同时提高了 GST 水平。此外,它还会上调 TNF-α (P = 0.001)、IL-1β (P = 0.001)和 COX-2 (P = 0.001)的表达。补充清酒,尤其是较高剂量的清酒,可逆转鱼藤酮对行为、氧化和炎症反应的不良影响。总之,日本清酒有望预防帕金森病,但还有待于进一步的临床研究。
{"title":"Investigating the therapeutic effects of a Japanese sake yeast supplement on a zebrafish model of Parkinson's disease: Antioxidant and inflammatory responses","authors":"Chang Li ,&nbsp;Meihe Li ,&nbsp;Yi Jin ,&nbsp;Qing An ,&nbsp;Huimin Dang ,&nbsp;Wei Gong","doi":"10.1016/j.exger.2024.112509","DOIUrl":"10.1016/j.exger.2024.112509","url":null,"abstract":"<div><p>Sake may potentially halt the progression of Parkinson's disease due to its properties, yet no studies have explored its effects. This preliminary study aimed to assess the impact of sake supplementation on Parkinson's disease using a zebrafish model. Sixty fish were divided into six groups: control, rotenone (ROT), and groups administered rotenone along with sake at concentrations of 25, 50, 75, and 100 mg/L (25S, 50S, 75S, and 100S). After 28 days of treatment, behavioral responses and the activities of catalase (CAT), superoxide dismutase (SOD), reduced glutathione (GSH), and glutathione-S-transferase (GST), as well as the expressions of TNF-α, IL-1β, and COX-2, were evaluated. The results indicated that rotenone administration significantly reduced crossing number (<em>P</em> = 0.001), entries in the top area (P = 0.001), and time spent in the top area (P = 0.001). It also markedly increased levels of TBARS and SH compared to the control group (<em>P</em> = 0.001). Rotenone significantly decreased CAT, SOD, and GSH activities while increasing GST levels. Furthermore, it upregulated the expressions of TNF-α (<em>P</em> = 0.001), IL-1β (P = 0.001), and COX-2 (P = 0.001). Supplementation with sake, particularly at higher doses, reversed the adverse effects of rotenone on behavioral, oxidative, and inflammatory responses. In conclusion, sake shows promise for preventing Parkinson's disease pending further clinical studies.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001517/pdfft?md5=8b6dd2c5a5629f194873cbb40347c14a&pid=1-s2.0-S0531556524001517-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis 根据性别差异分析,女性内皮细胞中的 IGF1R 和 FLT1 以及男性小胶质细胞中的 CHD2 在阿尔茨海默病中发挥重要作用。
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112512
Rong He , Jishuai Cheng , Yue Qiu , Yiwen Hu , Jia Liu , Ting-hua Wang , Xue Cao

Objective

This study investigated sex-specific pathogenesis mechanisms in Alzheimer's disease (AD) using single-nucleus RNA sequencing (snRNA-seq) data.

Methods

Data from the Gene Expression Omnibus (GEO) were searched using terms “Alzheimer's Disease”, “single cell”, and “Homo sapiens”. Studies excluding APOE E4 and including comprehensive gender information with 10× sequencing methods were selected, resulting in GSE157827 and GSE174367 datasets from human prefrontal cortex samples. Sex-stratified analyses were conducted on these datasets, and the outcomes of the analysis for GSE157827 were compared with those of GSE174367. The findings were validated using expression profiling from the mouse dataset GSE85162. Furthermore, real-time PCR experiments in mice further confirmed these findings. The Seurat R package was used to identify cell types, and batch effects were mitigated using the Harmony R package. Cell proportions by sex were compared using the Mann-Whitney-Wilcoxon test, and gene expression variability was displayed with an empirical cumulative distribution plot. Differentially expressed genes were identified using the FindMarkers function with the MAST test. Transcription factors were analyzed using the RcisTarget R package.

Results

Seven cell types were identified: astrocytes, endothelial cells, excitatory neurons, inhibitory neurons, microglia, oligodendrocytes, and oligodendrocyte progenitor cells. Additionally, five distinct subpopulations of both endothelial and microglial cells were also identified, respectively. Key findings included: (1) In endothelial cells, genes involved in synapse organization, such as Insulin Like Growth Factor 1 Receptor (IGF1R) and Fms Related Receptor Tyrosine Kinase 1(FLT1), showed higher expression in females with AD. (2) In microglial cells, genes in the ribosome pathway exhibited higher expression in males without AD compared to females (with or without AD) and males with AD. (3) Chromodomain Helicase DNA Binding Protein 2 (CHD2) negatively regulated gene expression in the ribosome pathway in male microglia, suppressing AD, this finding was further validated in mice. (4) Differences between Asians and Caucasians were observed based on sex and disease status stratification.

Conclusions

IGF1R and FLT1 in endothelial cells contribute to AD in females, while CHD2 negatively regulates ribosome pathway gene expression in male microglia, suppressing AD in humans and mice.

目的本研究利用单核 RNA 测序(snRNA-seq)数据研究阿尔茨海默病(AD)的性别特异性发病机制:方法:使用 "阿尔茨海默病"、"单细胞 "和 "智人 "等术语搜索基因表达总库(GEO)中的数据。筛选出排除 APOE E4 并包含全面性别信息的 10 倍测序方法的研究,得到了来自人类前额叶皮层样本的 GSE157827 和 GSE174367 数据集。对这些数据集进行了性别分层分析,并将 GSE157827 和 GSE174367 的分析结果进行了比较。研究结果通过小鼠数据集 GSE85162 的表达谱分析得到了验证。此外,小鼠的实时 PCR 实验进一步证实了这些发现。使用 Seurat R 软件包识别细胞类型,并使用 Harmony R 软件包减轻批次效应。使用 Mann-Whitney-Wilcoxon 检验比较了不同性别的细胞比例,并使用经验累积分布图显示了基因表达的变异性。使用 FindMarkers 函数和 MAST 检验确定差异表达基因。转录因子使用 RcisTarget R 软件包进行分析:结果:确定了七种细胞类型:星形胶质细胞、内皮细胞、兴奋性神经元、抑制性神经元、小胶质细胞、少突胶质细胞和少突胶质细胞祖细胞。此外,还分别确定了内皮细胞和小胶质细胞的五个不同亚群。主要发现包括(1)在内皮细胞中,参与突触组织的基因,如胰岛素样生长因子1受体(IGF1R)和Fms相关受体酪氨酸激酶1(FLT1),在AD女性患者中表达较高。(2)在小胶质细胞中,核糖体通路中的基因在无 AD 的男性中比女性(有或无 AD)和有 AD 的男性中表达更高。(3) 染色体链螺旋酶 DNA 结合蛋白 2(CHD2)对雄性小胶质细胞中核糖体通路的基因表达有负向调节作用,从而抑制 AD 的发生,这一发现在小鼠身上得到了进一步验证。(4)根据性别和疾病状态分层,观察到亚洲人和白种人之间的差异:结论:女性内皮细胞中的 IGF1R 和 FLT1 会导致 AD,而 CHD2 会负向调节男性小胶质细胞中核糖体通路基因的表达,从而抑制人类和小鼠的 AD。
{"title":"IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis","authors":"Rong He ,&nbsp;Jishuai Cheng ,&nbsp;Yue Qiu ,&nbsp;Yiwen Hu ,&nbsp;Jia Liu ,&nbsp;Ting-hua Wang ,&nbsp;Xue Cao","doi":"10.1016/j.exger.2024.112512","DOIUrl":"10.1016/j.exger.2024.112512","url":null,"abstract":"<div><h3>Objective</h3><p>This study investigated sex-specific pathogenesis mechanisms in Alzheimer's disease (AD) using single-nucleus RNA sequencing (snRNA-seq) data.</p></div><div><h3>Methods</h3><p>Data from the Gene Expression Omnibus (GEO) were searched using terms “Alzheimer's Disease”, “single cell”, and “<em>Homo sapiens</em>”. Studies excluding APOE E4 and including comprehensive gender information with 10× sequencing methods were selected, resulting in GSE157827 and GSE174367 datasets from human prefrontal cortex samples. Sex-stratified analyses were conducted on these datasets, and the outcomes of the analysis for GSE157827 were compared with those of GSE174367. The findings were validated using expression profiling from the mouse dataset GSE85162. Furthermore, real-time PCR experiments in mice further confirmed these findings. The Seurat R package was used to identify cell types, and batch effects were mitigated using the Harmony R package. Cell proportions by sex were compared using the Mann-Whitney-Wilcoxon test, and gene expression variability was displayed with an empirical cumulative distribution plot. Differentially expressed genes were identified using the FindMarkers function with the MAST test. Transcription factors were analyzed using the RcisTarget R package.</p></div><div><h3>Results</h3><p>Seven cell types were identified: astrocytes, endothelial cells, excitatory neurons, inhibitory neurons, microglia, oligodendrocytes, and oligodendrocyte progenitor cells. Additionally, five distinct subpopulations of both endothelial and microglial cells were also identified, respectively. Key findings included: (1) In endothelial cells, genes involved in synapse organization, such as Insulin Like Growth Factor 1 Receptor (IGF1R) and Fms Related Receptor Tyrosine Kinase 1(FLT1), showed higher expression in females with AD. (2) In microglial cells, genes in the ribosome pathway exhibited higher expression in males without AD compared to females (with or without AD) and males with AD. (3) Chromodomain Helicase DNA Binding Protein 2 (CHD2) negatively regulated gene expression in the ribosome pathway in male microglia, suppressing AD, this finding was further validated in mice. (4) Differences between Asians and Caucasians were observed based on sex and disease status stratification.</p></div><div><h3>Conclusions</h3><p>IGF1R and FLT1 in endothelial cells contribute to AD in females, while CHD2 negatively regulates ribosome pathway gene expression in male microglia, suppressing AD in humans and mice.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001542/pdfft?md5=69b26c32788760879df8c287229737d4&pid=1-s2.0-S0531556524001542-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medium-chain triglycerides combined with DHA improve cognitive function by inhibiting neurocyte apoptosis of the brain in SAMP8 mice 中链甘油三酯结合 DHA 可抑制 SAMP8 小鼠大脑神经细胞的凋亡,从而改善认知功能。
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112520
Yue Sun , Dezheng Zhou , Yue Wang , Zehao Wang , Dalong Zhang , Zhiyong Qian , Jing Yan , Zhenshu Li , Guowei Huang , Wen Li

Medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA, Cn-3, 22:6) are essential in improving cognitive function and protecting neurocytes. This study explored the effects of the combined intervention of MCTs and DHA on inhibiting neurocyte apoptosis of the brain and improving cognitive function in senescence-accelerated mouse-prone 8 (SAMP8). Four-month-old male SAMP8 mice were randomly divided into four treatment groups (12 mice/group): DHA, MCT, DHA + MCT, and control groups, which intervened for seven months. Twelve age-matched male senescence-accelerated mouse resistant 1 (SAMR1) was used as the natural aging group. TUNEL assay and HE staining were used to assess neurocyte apoptosis and damage in the brain of mice. Moreover, the cognitive function was analyzed using the Morris water maze (MWM) and open field (OF) tests. The results showed that the cognitive function of 11-month-old SAMP8 mice decreased with age, and further pathological examination revealed the damaged neurocyte structure, karyopyknosis, cell atrophy, and even apoptosis. MCTs combined with DHA supplementation could increase octanoic acid (C8:0), decanoic acid (C10:0), and DHA levels in the serum, inhibit neurocyte apoptosis, improve neurocyte damage, moreover delay age-related cognitive decline after seven-month treatment. Furthermore, combining MCTs and DHA was significantly more beneficial than MCTs or DHA alone. In conclusion, MCTs combined with DHA could delay cognitive decline by inhibiting neurocyte apoptosis of the brain in SAMP8 mice.

中链甘油三酯(MCTs)和二十二碳六烯酸(DHA,Cn-3,22:6)对改善认知功能和保护神经细胞至关重要。本研究探讨了 MCTs 和 DHA 联合干预对抑制大脑神经细胞凋亡和改善衰老加速小鼠易感基因 8(SAMP8)认知功能的影响。将四个月大的雄性 SAMP8 小鼠随机分为四个治疗组(每组 12 只):DHA组、MCT组、DHA + MCT组和对照组,干预7个月。12只年龄匹配的雄性抗衰老加速小鼠1(SAMR1)作为自然衰老组。采用 TUNEL 法和 HE 染色法评估小鼠大脑中神经细胞的凋亡和损伤。此外,还使用莫里斯水迷宫(MWM)和开阔地(OF)测试分析了小鼠的认知功能。结果显示,11 个月大的 SAMP8 小鼠的认知功能随着年龄的增长而下降,进一步的病理检查显示神经细胞结构受损、核分裂、细胞萎缩甚至凋亡。补充 MCTs 和 DHA 可以增加血清中辛酸(C8:0)、癸酸(C10:0)和 DHA 的含量,抑制神经细胞凋亡,改善神经细胞损伤,而且在治疗 7 个月后,还能延缓与年龄相关的认知能力下降。此外,结合使用 MCTs 和 DHA 比单独使用 MCTs 或 DHA 更有益。总之,MCTs 与 DHA 的结合可以通过抑制 SAMP8 小鼠大脑神经细胞的凋亡来延缓认知能力的衰退。
{"title":"Medium-chain triglycerides combined with DHA improve cognitive function by inhibiting neurocyte apoptosis of the brain in SAMP8 mice","authors":"Yue Sun ,&nbsp;Dezheng Zhou ,&nbsp;Yue Wang ,&nbsp;Zehao Wang ,&nbsp;Dalong Zhang ,&nbsp;Zhiyong Qian ,&nbsp;Jing Yan ,&nbsp;Zhenshu Li ,&nbsp;Guowei Huang ,&nbsp;Wen Li","doi":"10.1016/j.exger.2024.112520","DOIUrl":"10.1016/j.exger.2024.112520","url":null,"abstract":"<div><p>Medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA, C<sub>n-3, 22:6</sub>) are essential in improving cognitive function and protecting neurocytes. This study explored the effects of the combined intervention of MCTs and DHA on inhibiting neurocyte apoptosis of the brain and improving cognitive function in senescence-accelerated mouse-prone 8 (SAMP8). Four-month-old male SAMP8 mice were randomly divided into four treatment groups (12 mice/group): DHA, MCT, DHA + MCT, and control groups, which intervened for seven months. Twelve age-matched male senescence-accelerated mouse resistant 1 (SAMR1) was used as the natural aging group. TUNEL assay and HE staining were used to assess neurocyte apoptosis and damage in the brain of mice. Moreover, the cognitive function was analyzed using the Morris water maze (MWM) and open field (OF) tests. The results showed that the cognitive function of 11-month-old SAMP8 mice decreased with age, and further pathological examination revealed the damaged neurocyte structure, karyopyknosis, cell atrophy, and even apoptosis. MCTs combined with DHA supplementation could increase octanoic acid (C8:0), decanoic acid (C10:0), and DHA levels in the serum, inhibit neurocyte apoptosis, improve neurocyte damage, moreover delay age-related cognitive decline after seven-month treatment. Furthermore, combining MCTs and DHA was significantly more beneficial than MCTs or DHA alone. In conclusion, MCTs combined with DHA could delay cognitive decline by inhibiting neurocyte apoptosis of the brain in SAMP8 mice.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001621/pdfft?md5=18571e31f1b1ce5323941d1dede7cde5&pid=1-s2.0-S0531556524001621-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of imipramine on memory, adult neurogenesis, neuroinflammation, and mitochondrial biogenesis in a rat model of alzheimer's disease 丙咪嗪对阿尔茨海默病大鼠模型的记忆、成神经发生、神经炎症和线粒体生物生成的影响
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112517
Alireza Jamshidi Hasanabadi, Elmira Beirami, Mehdi Kamaei, Delaram Eslimi Esfahani

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and memory loss. Imipramine, a tricyclic antidepressant, has potent anti-inflammatory and antioxidant properties in the central nervous system. The aim of this study was to investigate the neuroprotective effects of imipramine on streptozotocin (STZ)-induced memory impairment. Male Wistar rats received an intracerebroventricular injection of STZ (3 mg/kg, 3 μl/ventricle) using the stereotaxic apparatus. The Morris water maze and passive avoidance tests were used to evaluate cognitive functions. 24 h after the STZ injection, imipramine was administered intraperitoneally at doses of 10 or 20 mg/kg for 14 consecutive days. The mRNA and protein levels of neurotrophic factors (BDNF and GDNF) and pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) were measured in the hippocampus using real-time PCR and ELISA techniques, respectively. In addition, real-time PCR was used to evaluate the mRNA levels of markers associated with neurogenesis (Nestin, DCX, and Ki67) and mitochondrial biogenesis (PGC-1α, NRF-1, and TFAM). The results showed that imipramine, especially at a dose of 20 mg/kg, effectively improved STZ-induced memory impairment. This improvement was associated with an increase in neurogenesis and neurotrophic factors and a decrease in neuroinflammation and mitochondrial biogenesis dysfunction. Based on these results, imipramine appears to be a promising therapeutic option for improving cognitive functions in neurodegenerative diseases such as AD.

阿尔茨海默病(AD)是一种进行性神经退行性疾病,以认知能力下降和记忆力丧失为特征。丙咪嗪是一种三环类抗抑郁药,在中枢神经系统中具有很强的抗炎和抗氧化作用。本研究旨在探讨丙咪嗪对链脲佐菌素(STZ)诱导的记忆损伤的神经保护作用。雄性 Wistar 大鼠使用立体定向装置接受 STZ(3 毫克/千克,3 微升/脑室)脑室内注射。采用莫里斯水迷宫和被动回避测试评估大鼠的认知功能。注射STZ 24小时后,腹腔注射丙咪嗪,剂量为10或20 mg/kg,连续14天。采用实时 PCR 和 ELISA 技术分别测定了海马中神经营养因子(BDNF 和 GDNF)和促炎细胞因子(IL-6、IL-1β 和 TNF-α)的 mRNA 和蛋白水平。此外,还利用实时 PCR 技术评估了与神经发生(Nestin、DCX 和 Ki67)和线粒体生物生成(PGC-1α、NRF-1 和 TFAM)相关的标记物的 mRNA 水平。结果表明,丙咪嗪(尤其是 20 毫克/千克的剂量)能有效改善 STZ 诱导的记忆损伤。这种改善与神经发生和神经营养因子的增加以及神经炎症和线粒体生物生成功能障碍的减少有关。基于这些结果,丙咪嗪似乎是一种很有希望改善神经退行性疾病(如阿氏症)认知功能的治疗选择。
{"title":"Effect of imipramine on memory, adult neurogenesis, neuroinflammation, and mitochondrial biogenesis in a rat model of alzheimer's disease","authors":"Alireza Jamshidi Hasanabadi,&nbsp;Elmira Beirami,&nbsp;Mehdi Kamaei,&nbsp;Delaram Eslimi Esfahani","doi":"10.1016/j.exger.2024.112517","DOIUrl":"10.1016/j.exger.2024.112517","url":null,"abstract":"<div><p>Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and memory loss. Imipramine, a tricyclic antidepressant, has potent anti-inflammatory and antioxidant properties in the central nervous system. The aim of this study was to investigate the neuroprotective effects of imipramine on streptozotocin (STZ)-induced memory impairment. Male Wistar rats received an intracerebroventricular injection of STZ (3 mg/kg, 3 μl/ventricle) using the stereotaxic apparatus. The Morris water maze and passive avoidance tests were used to evaluate cognitive functions. 24 h after the STZ injection, imipramine was administered intraperitoneally at doses of 10 or 20 mg/kg for 14 consecutive days. The mRNA and protein levels of neurotrophic factors (BDNF and GDNF) and pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) were measured in the hippocampus using real-time PCR and ELISA techniques, respectively. In addition, real-time PCR was used to evaluate the mRNA levels of markers associated with neurogenesis (Nestin, DCX, and Ki67) and mitochondrial biogenesis (PGC-1α, NRF-1, and TFAM). The results showed that imipramine, especially at a dose of 20 mg/kg, effectively improved STZ-induced memory impairment. This improvement was associated with an increase in neurogenesis and neurotrophic factors and a decrease in neuroinflammation and mitochondrial biogenesis dysfunction. Based on these results, imipramine appears to be a promising therapeutic option for improving cognitive functions in neurodegenerative diseases such as AD.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001591/pdfft?md5=11da86048ee0135fd14cf381542dd846&pid=1-s2.0-S0531556524001591-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calorie restriction and life-extending mutation downregulate miR-34a to facilitate lipid metabolism in the liver 卡路里限制和延寿突变会下调 miR-34a,从而促进肝脏的脂质代谢。
IF 3.9 Pub Date : 2024-07-10 DOI: 10.1016/j.exger.2024.112506
Sarah A. Ashiqueali , Xiang Zhu , Denise S. Wiesenborn , Adam Gesing , Augusto Schneider , Sarah A. Noureddine , Christian G. Correa-Garcia , Michal M. Masternak , Shadab A. Siddiqi

Ames dwarf mice (df/df) display delayed aging relative to their normal (N) siblings, living approximately 40–60 % longer. As such, investigating the mechanisms that enable these organisms to have extended lifespan is useful for the development of interventions to slow aging and deter age-related disease. Nonalcoholic fatty liver disease (NAFLD) is a condition that is characterized by the accumulation of excess adipose tissue in the liver. Previous studies highlight the potential of calorie restriction (CR) in promoting longevity, but little is known about its effects on the biomolecular processes that govern NAFLD. In this study, we examined the role of 6-month CR on genes regulating lipid metabolism in the livers of long-living df/df mice and their N littermates. Importantly, our findings showed significant downregulation of miR-34a-5p in N-CR mice and df/df mice regardless of dietary regimen. Alongside, our RT-PCR results indicated that downregulation of miR-34a-5p is correlated with the expression of metabolism-associated mRNAs involved in modulating the processes of de novo lipogenesis (DNL), fatty acid oxidation (FAO), very-low density lipoprotein transport (VLDL-T), and reverse cholesterol transport (RCT). To further verify the role of miR-34a-5p in regulating metabolic processes, we transfected the human liver cancer (HepG2) cell line with miR-34a mimic, and studied its effect on direct targets Sirt1, Ampk, and Ppara as well as downstream lipid transport regulating genes. Our findings suggest that CR and df/df life extending mutation are robust drivers of the miR-34a-5p signaling pathway and prevent the pathogenesis of age-related diseases by improving overall lipid homeostasis.

艾姆斯侏儒小鼠(df/df)与正常(N)小鼠相比衰老延迟,寿命长约 40-60%。因此,研究这些生物延长寿命的机制有助于开发减缓衰老和阻止老年相关疾病的干预措施。非酒精性脂肪肝(NAFLD)是一种以肝脏中堆积过多脂肪组织为特征的疾病。以往的研究强调了卡路里限制(CR)在促进长寿方面的潜力,但对其对支配非酒精性脂肪肝的生物分子过程的影响却知之甚少。在这项研究中,我们研究了为期 6 个月的卡路里限制对长寿 df/df 小鼠及其 N 同窝小鼠肝脏中调控脂质代谢基因的作用。重要的是,我们的研究结果表明,无论采用哪种饮食方案,N-CR 小鼠和 df/df 小鼠肝脏中的 miR-34a-5p 都出现了明显的下调。此外,我们的 RT-PCR 结果表明,miR-34a-5p 的下调与参与调节新生脂肪生成(DNL)、脂肪酸氧化(FAO)、极低密度脂蛋白转运(VLDL-T)和胆固醇反向转运(RCT)过程的代谢相关 mRNA 的表达有关。为了进一步验证 miR-34a-5p 在调节代谢过程中的作用,我们用 miR-34a 模拟物转染了人肝癌(HepG2)细胞系,并研究了它对直接靶标 Sirt1、Ampk 和 Ppara 以及下游脂质转运调节基因的影响。我们的研究结果表明,CR 和 df/df 延长寿命突变是 miR-34a-5p 信号通路的强大驱动力,可通过改善整体脂质稳态来预防老年相关疾病的发病机制。
{"title":"Calorie restriction and life-extending mutation downregulate miR-34a to facilitate lipid metabolism in the liver","authors":"Sarah A. Ashiqueali ,&nbsp;Xiang Zhu ,&nbsp;Denise S. Wiesenborn ,&nbsp;Adam Gesing ,&nbsp;Augusto Schneider ,&nbsp;Sarah A. Noureddine ,&nbsp;Christian G. Correa-Garcia ,&nbsp;Michal M. Masternak ,&nbsp;Shadab A. Siddiqi","doi":"10.1016/j.exger.2024.112506","DOIUrl":"10.1016/j.exger.2024.112506","url":null,"abstract":"<div><p>Ames dwarf mice (df/df) display delayed aging relative to their normal (N) siblings, living approximately 40–60 % longer. As such, investigating the mechanisms that enable these organisms to have extended lifespan is useful for the development of interventions to slow aging and deter age-related disease. Nonalcoholic fatty liver disease (NAFLD) is a condition that is characterized by the accumulation of excess adipose tissue in the liver. Previous studies highlight the potential of calorie restriction (CR) in promoting longevity, but little is known about its effects on the biomolecular processes that govern NAFLD. In this study, we examined the role of 6-month CR on genes regulating lipid metabolism in the livers of long-living df/df mice and their N littermates. Importantly, our findings showed significant downregulation of miR-34a-5p in N-CR mice and df/df mice regardless of dietary regimen. Alongside, our RT-PCR results indicated that downregulation of miR-34a-5p is correlated with the expression of metabolism-associated mRNAs involved in modulating the processes of de novo lipogenesis (DNL), fatty acid oxidation (FAO), very-low density lipoprotein transport (VLDL-T), and reverse cholesterol transport (RCT). To further verify the role of miR-34a-5p in regulating metabolic processes, we transfected the human liver cancer (HepG2) cell line with miR-34a mimic, and studied its effect on direct targets <em>Sirt1, Ampk,</em> and <em>Ppara</em> as well as downstream lipid transport regulating genes. Our findings suggest that CR and df/df life extending mutation are robust drivers of the miR-34a-5p signaling pathway and prevent the pathogenesis of age-related diseases by improving overall lipid homeostasis.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001487/pdfft?md5=388e369c09954bb18ed7e5979bf8c715&pid=1-s2.0-S0531556524001487-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosomes derived from hTERT-immortalized cells delay cellular senescence of human fibroblasts 从 hTERT-immortalized细胞中提取的外泌体可延缓人成纤维细胞的衰老。
IF 3.9 Pub Date : 2024-07-09 DOI: 10.1016/j.exger.2024.112508
Yang Liu, Zhaoying Sheng, Linlin Sun

hTERT gene therapies hold significant promise for treating age-related diseases. However, further research is required to address the challenges of delivery and ethical considerations. We hypothesized that exosomes derived from hTERT-immortalized cells could function similarly to hTERT gene therapies by maintaining telomere length and attenuating cellular senescence biomarkers. In this study, we overexpressed the hTERT gene in Human Foreskin Fibroblast-1 cells (HFF cells) to produce hTERT-immortalized HFF cells (hT-HFF cells). We then used exosomes derived from these hT-HFF cells to treat human fibroblasts, HFF cells. Our results demonstrated that these exosomes effectively attenuated biomarkers of cellular senescence in HFF cells. Furthermore, analysis revealed that hTERT mRNA was indeed packaged into the exosomes from hT-HFF cells. This mRNA was capable of elongating telomeres and delaying cellular senescence in HFF cells. Therefore, exosomes from hT-HFF cells show potential as a treatment for age-related diseases.

hTERT 基因疗法在治疗老年相关疾病方面大有可为。然而,还需要进一步的研究来应对递送和伦理方面的挑战。我们假定,从hTERT-immortalized细胞中提取的外泌体可以通过维持端粒长度和减弱细胞衰老生物标志物发挥类似于hTERT基因疗法的作用。在这项研究中,我们在人前皮成纤维细胞-1细胞(HFF细胞)中过表达了hTERT基因,从而产生了hTERT-immortalized HFF细胞(hT-HFF细胞)。然后,我们使用从这些 hT-HFF 细胞中提取的外泌体处理人成纤维细胞、HFF 细胞。我们的研究结果表明,这些外泌体有效地减轻了HFF细胞中细胞衰老的生物标志物。此外,分析表明,hTERT mRNA确实被包装到了来自hT-HFF细胞的外泌体中。这种mRNA能够延长端粒,延缓HFF细胞的衰老。因此,hT-HFF细胞的外泌体具有治疗老年相关疾病的潜力。
{"title":"Exosomes derived from hTERT-immortalized cells delay cellular senescence of human fibroblasts","authors":"Yang Liu,&nbsp;Zhaoying Sheng,&nbsp;Linlin Sun","doi":"10.1016/j.exger.2024.112508","DOIUrl":"10.1016/j.exger.2024.112508","url":null,"abstract":"<div><p>hTERT gene therapies hold significant promise for treating age-related diseases. However, further research is required to address the challenges of delivery and ethical considerations. We hypothesized that exosomes derived from hTERT-immortalized cells could function similarly to hTERT gene therapies by maintaining telomere length and attenuating cellular senescence biomarkers. In this study, we overexpressed the hTERT gene in Human Foreskin Fibroblast-1 cells (HFF cells) to produce hTERT-immortalized HFF cells (hT-HFF cells). We then used exosomes derived from these hT-HFF cells to treat human fibroblasts, HFF cells. Our results demonstrated that these exosomes effectively attenuated biomarkers of cellular senescence in HFF cells. Furthermore, analysis revealed that hTERT mRNA was indeed packaged into the exosomes from hT-HFF cells. This mRNA was capable of elongating telomeres and delaying cellular senescence in HFF cells. Therefore, exosomes from hT-HFF cells show potential as a treatment for age-related diseases.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001505/pdfft?md5=79a89ee5d42912c1229656ab3015e8c4&pid=1-s2.0-S0531556524001505-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of pattern-recognition-measured daily activities with sarcopenia and sarcopenic obesity in old age: The IMPACT65+ study 模式识别测量的日常活动与老年肌肉疏松症和肌肉疏松性肥胖症的关系:IMPACT65+研究。
IF 3.9 Pub Date : 2024-07-08 DOI: 10.1016/j.exger.2024.112511
Julia Wiedmaier-Barros , Sara Higueras-Fresnillo , Kabir P. Sadarangani , David Martínez-Gómez

Background

Physical activity has shown beneficial effects for a good state of muscles in aging, but the specific activities of daily living that could be protective remains unclear. This study aimed to analyse the associations of different pattern-recognition-measured daily activities with sarcopenia and sarcopenic obesity in a sample of older adults.

Methods

200 community-dwelling older adults wore the Intelligent Device for Energy Expenditure and Activity for two consecutive days. Twelve major daily activities recorded were merged in to three common intensity categories: sedentary behaviour (SB), light physical activity (LPA) and moderate-to-vigorous physical activity (MVPA). For physical performance measurements included, hand grip dynamometer and chair-stand tests were used. Skeletal muscle mass and fat mass were estimated by bioelectrical impedance analysis. Associations of daily activities with the study variables were examined using linear regression models.

Results

There were no significant associations between total time spent in SB, LPA, or MVPA and sarcopenia. Sarcopenic obesity showed a negative association with total time spent in MVPA [ß (95%CI): −0.29 (−0.41, −0.17)]. Walk at a brisk pace was significatively associated with lower limb physical performance, muscle mass and fat mass % [ß (95%CI): 1.15 (0.40, 1.91); 1.45 (0.68, 2.22) and -2.63 (−4.12, −1.14) respectively]. Other MVPA activities were also significatively associated with the same sarcopenic obesity components [ß (95%CI): 4.65 (0.55, 8.75); 8.59 (4.51, 12.67) and -13.98 (−21.96, −5.99) respectively].

Conclusion

Time spent in daily activities of moderate-to-vigorous intensity is negatively associated with sarcopenic obesity but not with sarcopenia.

背景:体育活动对老年人肌肉的良好状态有好处,但具体哪些日常生活活动具有保护作用仍不清楚。本研究旨在分析老年人样本中不同模式识别测量的日常活动与肌肉疏松症和肌肉疏松性肥胖的关联。记录的 12 种主要日常活动被合并为三种常见强度类别:久坐行为(SB)、轻体力活动(LPA)和中到剧烈体力活动(MVPA)。体能测量包括手握式测力计和椅子站立测试。骨骼肌质量和脂肪质量通过生物电阻抗分析进行估算。使用线性回归模型检验了日常活动与研究变量之间的关系:结果:SB、LPA 或 MVPA 所花费的总时间与肌肉疏松症之间没有明显关联。肌肉疏松性肥胖症与 MVPA 的总时间呈负相关[ß (95%CI):-0.29 (-0.41, -0.17)]。快步走与下肢体能表现、肌肉质量和脂肪质量百分比显著相关[ß(95%CI):分别为1.15(0.40,1.91);1.45(0.68,2.22)和-2.63(-4.12,-1.14)]。其他 MVPA 活动也与相同的肌肉疏松性肥胖成分显著相关[ß(95%CI):分别为 4.65(0.55,8.75);8.59(4.51,12.67)和-13.98(-21.96,-5.99)]:结论:从事中等至剧烈强度日常活动的时间与肌肉疏松性肥胖症呈负相关,但与肌肉疏松症无关。
{"title":"Associations of pattern-recognition-measured daily activities with sarcopenia and sarcopenic obesity in old age: The IMPACT65+ study","authors":"Julia Wiedmaier-Barros ,&nbsp;Sara Higueras-Fresnillo ,&nbsp;Kabir P. Sadarangani ,&nbsp;David Martínez-Gómez","doi":"10.1016/j.exger.2024.112511","DOIUrl":"10.1016/j.exger.2024.112511","url":null,"abstract":"<div><h3>Background</h3><p>Physical activity has shown beneficial effects for a good state of muscles in aging, but the specific activities of daily living that could be protective remains unclear. This study aimed to analyse the associations of different pattern-recognition-measured daily activities with sarcopenia and sarcopenic obesity in a sample of older adults.</p></div><div><h3>Methods</h3><p>200 community-dwelling older adults wore the Intelligent Device for Energy Expenditure and Activity for two consecutive days. Twelve major daily activities recorded were merged in to three common intensity categories: sedentary behaviour (SB), light physical activity (LPA) and moderate-to-vigorous physical activity (MVPA). For physical performance measurements included, hand grip dynamometer and chair-stand tests were used. Skeletal muscle mass and fat mass were estimated by bioelectrical impedance analysis. Associations of daily activities with the study variables were examined using linear regression models.</p></div><div><h3>Results</h3><p>There were no significant associations between total time spent in SB, LPA, or MVPA and sarcopenia. Sarcopenic obesity showed a negative association with total time spent in MVPA [ß (95%CI): −0.29 (−0.41, −0.17)]. Walk at a brisk pace was significatively associated with lower limb physical performance, muscle mass and fat mass % [ß (95%CI): 1.15 (0.40, 1.91); 1.45 (0.68, 2.22) and -2.63 (−4.12, −1.14) respectively]. Other MVPA activities were also significatively associated with the same sarcopenic obesity components [ß (95%CI): 4.65 (0.55, 8.75); 8.59 (4.51, 12.67) and -13.98 (−21.96, −5.99) respectively].</p></div><div><h3>Conclusion</h3><p>Time spent in daily activities of moderate-to-vigorous intensity is negatively associated with sarcopenic obesity but not with sarcopenia.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001530/pdfft?md5=d576ad6c3350a6c09d3b322ee1fd0bcd&pid=1-s2.0-S0531556524001530-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential benefits of PGC-1α in treating Alzheimer's disease are dependent on the integrity of the LLKYL L3 motif: Effect of regulating mitochondrial axonal transportation PGC-1α 治疗阿尔茨海默病的潜在益处取决于 LLKYL L3 motif 的完整性:调节线粒体轴突运输的效果
IF 3.9 Pub Date : 2024-07-05 DOI: 10.1016/j.exger.2024.112514
Hou-Zhen Shi , Yi-Jie Wang , Yu-Xin Wang , Long-Fei Xu , Wen Pan , Lei Shi , Jia Wang

Mitochondrial dysfunction is a prominent hallmark of Alzheimer's disease (AD). The transcriptional coactivator PPARγ coactivator 1 (PGC-1a) has been identified as a key regulator of mitochondrial biogenesis and function. However, the precise structure/function relationship between PGC-1a and mitochondrial quality control remains incompletely understood. In this study, we investigated the impact of PGC-1a on AD pathology and its underlying mechanisms with a specific focus on mitochondrial axonal transport. Additionally, we generated two PGC-1α mutants by substituting leucine residues at positions 148 and 149 within the LKKLL motif or at positions 209 and 210 within the LLKYL motif with alanine. Subsequently, we examined the effects of these mutants on mutAPP-induced abnormalities in anterograde and retrograde axonal transport, disrupted mitochondrial distribution, and impaired mitophagy.

Mutagenesis studies revealed that the LLKYL motif at amino acid position 209–210 within PGC-1α plays an essential role in its interaction with estrogen-related receptors (ERRα), which is necessary for restoring normal mitochondrial anterograde axonal transport, maintaining proper mitochondrial distribution, and ultimately preventing neuronal apoptosis. Furthermore, it was found that the Leu-rich motif at amino acids 209–210 within PGC-1α is crucial for rescuing mutAPP-induced impairment in mitophagy and loss of membrane potential by restoring normal mitochondrial retrograde axonal transport. Conversely, mutation of residues 148 and 149 in the LKKLL motif does not compromise the effectiveness of PGC-1α. These findings provide valuable insights into the molecular determinants governing specificity of action for PGC-1α involved in regulating mutAPP-induced deficits in mitochondrial axonal trafficking. Moreover, they suggest a potential therapeutic target for addressing Alzheimer's disease.

线粒体功能障碍是阿尔茨海默病(AD)的一个显著特征。转录辅激活子 PPARγ 辅激活子 1(PGC-1a)已被确定为线粒体生物生成和功能的关键调节因子。然而,PGC-1a 与线粒体质量控制之间的确切结构/功能关系仍不完全清楚。在本研究中,我们研究了PGC-1a对AD病理的影响及其潜在机制,并特别关注线粒体轴突运输。此外,我们还生成了两种 PGC-1α 突变体,即用丙氨酸取代 LKKLL 矩阵中 148 和 149 位的亮氨酸残基或 LLKYL 矩阵中 209 和 210 位的亮氨酸残基。随后,我们研究了这些突变体对 mutAPP 诱导的轴突前向和逆向运输异常、线粒体分布紊乱和有丝分裂障碍的影响。突变研究发现,PGC-1α中位于第209-210位氨基酸的LLKYL基序在其与雌激素相关受体(ERRα)的相互作用中起着至关重要的作用,而ERRα是恢复正常线粒体前向轴突运输、维持线粒体正常分布以及最终防止神经元凋亡所必需的。此外,研究还发现,PGC-1α中位于209-210氨基酸的富含Leu的基序对于通过恢复正常的线粒体逆向轴突运输来挽救mutAPP诱导的有丝分裂障碍和膜电位丧失至关重要。相反,LKKLL motif 中残基 148 和 149 的突变并不影响 PGC-1α 的有效性。这些研究结果为我们提供了宝贵的信息,使我们能够深入了解 PGC-1α 参与调节 mutAPP 诱导的线粒体轴突运输缺陷的特异性作用的分子决定因素。此外,这些发现还提出了一种治疗阿尔茨海默病的潜在靶点。
{"title":"The potential benefits of PGC-1α in treating Alzheimer's disease are dependent on the integrity of the LLKYL L3 motif: Effect of regulating mitochondrial axonal transportation","authors":"Hou-Zhen Shi ,&nbsp;Yi-Jie Wang ,&nbsp;Yu-Xin Wang ,&nbsp;Long-Fei Xu ,&nbsp;Wen Pan ,&nbsp;Lei Shi ,&nbsp;Jia Wang","doi":"10.1016/j.exger.2024.112514","DOIUrl":"https://doi.org/10.1016/j.exger.2024.112514","url":null,"abstract":"<div><p>Mitochondrial dysfunction is a prominent hallmark of Alzheimer's disease (AD). The transcriptional coactivator PPARγ coactivator 1 (PGC-1a) has been identified as a key regulator of mitochondrial biogenesis and function. However, the precise structure/function relationship between PGC-1a and mitochondrial quality control remains incompletely understood. In this study, we investigated the impact of PGC-1a on AD pathology and its underlying mechanisms with a specific focus on mitochondrial axonal transport. Additionally, we generated two PGC-1α mutants by substituting leucine residues at positions 148 and 149 within the LKKLL motif or at positions 209 and 210 within the LLKYL motif with alanine. Subsequently, we examined the effects of these mutants on mutAPP-induced abnormalities in anterograde and retrograde axonal transport, disrupted mitochondrial distribution, and impaired mitophagy.</p><p>Mutagenesis studies revealed that the LLKYL motif at amino acid position 209–210 within PGC-1α plays an essential role in its interaction with estrogen-related receptors (ERRα), which is necessary for restoring normal mitochondrial anterograde axonal transport, maintaining proper mitochondrial distribution, and ultimately preventing neuronal apoptosis. Furthermore, it was found that the Leu-rich motif at amino acids 209–210 within PGC-1α is crucial for rescuing mutAPP-induced impairment in mitophagy and loss of membrane potential by restoring normal mitochondrial retrograde axonal transport. Conversely, mutation of residues 148 and 149 in the LKKLL motif does not compromise the effectiveness of PGC-1α. These findings provide valuable insights into the molecular determinants governing specificity of action for PGC-1α involved in regulating mutAPP-induced deficits in mitochondrial axonal trafficking. Moreover, they suggest a potential therapeutic target for addressing Alzheimer's disease.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001566/pdfft?md5=4eade415f50b387a84357ce0380e5bd5&pid=1-s2.0-S0531556524001566-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141539578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
β-Alanine supplementation improves fractional anisotropy scores in the hippocampus and amygdala in 60–80-year-old men and women 补充β-丙氨酸可改善 60-80 岁男性和女性海马和杏仁核的分数各向异性得分
IF 3.9 Pub Date : 2024-07-05 DOI: 10.1016/j.exger.2024.112513
Ishay Ostfeld , Amit Zamir , Tavor Ben-Zeev , Chagai Levi , Yftach Gepner , David Peled , Daniel Barazany , Shmuel Springer , Jay R. Hoffman

Recently, β-alanine (BA) supplementation was shown to improve cognitive function in older adults with decreased cognitive function. Mechanisms supporting these improvements have not been well defined. This study examined the effects of 10-weeks of BA supplementation on changes in circulating brain inflammatory markers, brain derived neurotrophic factor (BDNF), and brain morphology. Twenty participants were initially randomized into BA (2.4 g·d−1) or placebo (PL) groups. At each testing session, participants provided a resting blood sample and completed the Montreal cognitive assessment (MoCA) test and magnetic resonance imaging, which included diffusion tensor imaging to assess brain tissue integrity. Only participants that scored at or below normal for the MoCA assessment were analyzed (6 BA and 4 PL). The Mann-Whitney U test was used to examine Δ (POST–PRE) differences between the groups. No differences in Δ scores were noted in any blood marker (BDNF, CRP, TNF-α and GFAP). Changes in fractional anisotropy scores were significantly greater for BA than PL in the right hippocampus (p = 0.033) and the left amygdala (p = 0.05). No other differences were noted. The results provide a potential mechanism of how BA supplementation may improve cognitive function as reflected by improved tissue integrity within the hippocampus and amygdala.

最近,β-丙氨酸(BA)补充剂被证明可以改善认知功能下降的老年人的认知功能。支持这些改善的机制尚未明确。本研究考察了为期 10 周的 BA 补充剂对循环脑炎症标志物、脑源性神经营养因子 (BDNF) 和脑形态变化的影响。20 名参与者最初被随机分为 BA 组(2.4 克/日-1)或安慰剂组(PL)。在每次测试时,参与者都要提供静息血样,并完成蒙特利尔认知评估(MoCA)测试和磁共振成像,其中包括用于评估脑组织完整性的弥散张量成像。只分析了在 MoCA 评估中得分达到或低于正常水平的参与者(6 名 BA 和 4 名 PL)。采用 Mann-Whitney U 检验来检验两组之间的 Δ(POST-PRE)差异。任何血液标记物(BDNF、CRP、TNF-α 和 GFAP)的Δ评分均无差异。在右侧海马(p = 0.033)和左侧杏仁核(p = 0.05),BA 的分数各向异性得分变化明显大于 PL。没有发现其他差异。这些结果提供了一种潜在的机制,说明补充 BA 可通过改善海马和杏仁核内的组织完整性来改善认知功能。
{"title":"β-Alanine supplementation improves fractional anisotropy scores in the hippocampus and amygdala in 60–80-year-old men and women","authors":"Ishay Ostfeld ,&nbsp;Amit Zamir ,&nbsp;Tavor Ben-Zeev ,&nbsp;Chagai Levi ,&nbsp;Yftach Gepner ,&nbsp;David Peled ,&nbsp;Daniel Barazany ,&nbsp;Shmuel Springer ,&nbsp;Jay R. Hoffman","doi":"10.1016/j.exger.2024.112513","DOIUrl":"https://doi.org/10.1016/j.exger.2024.112513","url":null,"abstract":"<div><p>Recently, β-alanine (BA) supplementation was shown to improve cognitive function in older adults with decreased cognitive function. Mechanisms supporting these improvements have not been well defined. This study examined the effects of 10-weeks of BA supplementation on changes in circulating brain inflammatory markers, brain derived neurotrophic factor (BDNF), and brain morphology. Twenty participants were initially randomized into BA (2.4 g·d<sup>−1</sup>) or placebo (PL) groups. At each testing session, participants provided a resting blood sample and completed the Montreal cognitive assessment (MoCA) test and magnetic resonance imaging, which included diffusion tensor imaging to assess brain tissue integrity. Only participants that scored at or below normal for the MoCA assessment were analyzed (6 BA and 4 PL). The Mann-Whitney <em>U</em> test was used to examine Δ (POST–PRE) differences between the groups. No differences in Δ scores were noted in any blood marker (BDNF, CRP, TNF-α and GFAP). Changes in fractional anisotropy scores were significantly greater for BA than PL in the right hippocampus (<em>p</em> = 0.033) and the left amygdala (<em>p</em> = 0.05). No other differences were noted. The results provide a potential mechanism of how BA supplementation may improve cognitive function as reflected by improved tissue integrity within the hippocampus and amygdala.</p></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0531556524001554/pdfft?md5=571a7cf4b33681093fc09218357de060&pid=1-s2.0-S0531556524001554-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141539579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental gerontology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1